# Aeglea BioTherapeutics Holdings, LLC — Form D/A

Aeglea BioTherapeutics Holdings, LLC of AUSTIN, TX, a company, filed a Form D amendment with the SEC on 2014-07-28. The offering totals $11.0M, of which $10.7M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2014-07-28
- Form: D/A
- Accession: 0001595365-14-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $11.0M
- Amount sold: $10.7M
- Remaining: $293K
- Investors: 10
- Date of first sale: 2013-12-24
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-209533

## Issuer

- Name: Aeglea BioTherapeutics Holdings, LLC
- CIK: 0001595365
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 815-A BRAZOS STREET, AUSTIN, TX, 78701
- Phone: 650-387-5294

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| George Georgiou | Director | Edinburgh, X0 |
| David Lowe | Director | Walnut Creek, CA |
| Armen Shanafelt | Director | Austin, TX |
| HENRY SKINNER | Director | SAN DIEGO, CA |
| David Lowe | Executive Officer | Walnut Creek, CA |
| Charles York | Executive Officer | Austin, TX |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2014-01-08](https://search.stillhousedata.com/formd/0001595365-14-000001) | D | $9.5M | $5.1M |

## More

- [CIK 1595365 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1595365&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001595365-14-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.